Therefore, an increase in the intestinal gluconeogenesis and the stimulation of the hepato-portal glucose sensor via a GLUT-2-dependent pathway has been postulated as one of the mechanisms through which RYGB improves insulin sensitivity and reduces food intake contributing to the resolution of hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.